Zhu M - Search Results

1

Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.

Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Zaremba S, et al. Among authors: zhu m. Cancer Res. 1997 Oct 15;57(20):4570-7. Cancer Res. 1997. PMID: 9377571

2

The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.

Tsang KY, Zhu M, Even J, Gulley J, Arlen P, Schlom J. Tsang KY, et al. Among authors: zhu m. Cancer Res. 2001 Oct 15;61(20):7568-76. Cancer Res. 2001. PMID: 11606396

3

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.

Correale P, Walmsley K, Nieroda C, Zaremba S, Zhu M, Schlom J, Tsang KY. Correale P, et al. Among authors: zhu m. J Natl Cancer Inst. 1997 Feb 19;89(4):293-300. doi: 10.1093/jnci/89.4.293. J Natl Cancer Inst. 1997. PMID: 9048833

4

Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.

Correale P, Walmsley K, Zaremba S, Zhu M, Schlom J, Tsang KY. Correale P, et al. Among authors: zhu m. J Immunol. 1998 Sep 15;161(6):3186-94. J Immunol. 1998. PMID: 9743387

5

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

Tsang KY, Zhu M, Nieroda CA, Correale P, Zaremba S, Hamilton JM, Cole D, Lam C, Schlom J. Tsang KY, et al. Among authors: zhu m. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2439-49. Clin Cancer Res. 1997. PMID: 9815645

6

Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.

Zhu M, Terasawa H, Gulley J, Panicali D, Arlen P, Schlom J, Tsang KY. Zhu M, et al. Cancer Res. 2001 May 1;61(9):3725-34. Cancer Res. 2001. PMID: 11325845

7

Generation and characterization of a novel single-gene-encoded single-chain immunoglobulin molecule with antigen binding activity and effector functions.

Lee HS, Shu L, De Pascalis R, Giuliano M, Zhu M, Padlan EA, Hand PH, Schlom J, Hong HJ, Kashmiri SV. Lee HS, et al. Among authors: zhu m. Mol Immunol. 1999 Jan;36(1):61-71. doi: 10.1016/s0161-5890(98)00109-6. Mol Immunol. 1999. PMID: 10369421

8

Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas.

Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Jones R, Borkowski A, Harris CC. Greenblatt MS, et al. Among authors: zhu m. Cancer Res. 1997 Feb 1;57(3):426-32. Cancer Res. 1997. PMID: 9012469

9

The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma.

Zhu M, London WT, Duan LX, Feitelson MA. Zhu M, et al. Int J Cancer. 1993 Oct 21;55(4):571-6. doi: 10.1002/ijc.2910550409. Int J Cancer. 1993. PMID: 8406983

10

Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid.

Caffrey PB, Zhu M, Zhang Y, Chinen N, Frenkel GD. Caffrey PB, et al. Among authors: zhu m. Cancer Lett. 1999 Feb 8;136(1):47-52. doi: 10.1016/s0304-3835(98)00307-3. Cancer Lett. 1999. PMID: 10211938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,304 results

Search Page

Filters